Entasis Therapeutics Holdings Inc

NASDAQ:ETTX  
2.79
+0.10 (+3.72%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Entasis Therapeutics Holdings Inc Stock, NASDAQ:ETTX

35 Gatehouse Drive, 35 Gatehouse Park Drive, Waltham, Massachusetts 02451
Phone: +1.781.810.0120
Number of Employees: 47

Description

Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections. Its anti-infective discovery platform has produced a pipeline of differentiated programs, which is bacterial infections, including ETX2514SUL (targeting Acinetobacter baumannii infections), ETX0282CPDP (targeting Enterobacteriaceae infections), Non-Beta-lactam PBP inhibitor, and Zoliflodacin. The company was founded in May 2015 and is headquartered in Waltham, MA.